In animal experiments, APE lowered fasting and random blood glucose, total cholesterol, triglycerides, LDL-C, AST, ALT, and serum lipopolysaccharide while increasing HDL-C, and alleviated hepatic steatosis. This evidence concerns the gene GPT and fatty liver disease.